Alexey V. Kibardin
Moscow, MOW 117997, Russian Federation
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
GD2-Targeted Minibody-Drug Conjugates Match the Potency of IgG-Based ADCs in a Mouse Cancer Model.
Journal: International journal of molecular sciences
Published: January 19, 2026
Endocytosis Properties of GD2-Specific Antibodies in Tumor Cells.
Journal: Biochemistry. Biokhimiia
Published: May 14, 2025
The Problem of Molecular Target Choice for CAR-T Cells in Acute Myeloid Leukemia Therapy.
Journal: International journal of molecular sciences
Published: April 08, 2025
Mechanisms of Biological Effects of Ionic Liquids: From Single Cells to Multicellular Organisms.
Journal: Chemical reviews
Published: April 15, 2024
Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment-Drug Conjugates Carrying Maytansinoids DM1 and DM4.
Journal: Current issues in molecular biology
Published: August 28, 2023
Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells.
Journal: International journal of molecular sciences
Published: November 29, 2022
Mutated Flt3Lg Provides Reduced Flt3 Recycling Compared to Wild-Type Flt3Lg and Retains the Specificity of Flt3Lg-Based CAR T-Cell Targeting in AML Models.
Journal: International journal of molecular sciences
Published: October 26, 2022
Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors.
Journal: Journal for immunotherapy of cancer
Published: June 01, 2022
Human Short Peptidoglycan Recognition Protein PGLYRP1/Tag-7/PGRP-S Inhibits Listeria monocytogenes Intracellular Survival in Macrophages.
Journal: Frontiers in cellular and infection microbiology
Published: July 13, 2020
Platelet rich plasma and growth factors cocktails for diabetic foot ulcers treatment: State of art developments and future prospects.
Journal: Diabetes & metabolic syndrome
Published: August 22, 2017
Last Updated: 09/26/2026